US FDA Approves Blood-Drawing Robot to Address Shortage of Medical Professionals
The U.S. Food and Drug Administration (FDA) has officially approved "Aletta," an autonomous blood-drawing robot developed by a Dutch startup. This robot represents a new technology capable of performing blood draws accurately without human intervention.
Currently, many countries, including the United States, are facing a significant shortage of medical professionals such as nurses and clinical laboratory technicians, which has become a major challenge in the field. By automating the basic medical procedure of drawing blood, this robot aims to reduce the burden on medical staff and provide more efficient healthcare services.
"Aletta" combines advanced sensors and AI technology to accurately locate a patient's veins and safely insert the needle. This is expected to reduce errors during blood collection while also alleviating pain and anxiety for patients.
In recent years, the use of robotic technology in the medical field has been advancing rapidly. There has previously been news of a humanoid robot successfully performing surgery, and in the future, robots that support surgeons and nurses may become a common sight in hospitals around the world.
In Japan, the shortage of labor in medical settings is also a serious issue. Attention is now focused on how cutting-edge technologies like the one approved today might be utilized in Japanese medical facilities in the future.